HealthEquity's Q2 FY2027 results, released on August 27, showed an 8% year-over-year increase in revenue to $347 million, surpassing the 7% growth rate from the first half of the year. Adjusted EBITDA jumped 11% to $167 million, achieving a record-high margin of 48%. The company's total Health Savings Accounts (HSAs) reached 10.7 million, with new HSAs growing 24% year-over-year to 202,000. Based on this performance, management raised its full-year revenue and profit guidance, now expecting full-year revenue between $1.411 billion and $1.421 billion, and adjusted EBITDA between $628 million and $636 million. The company's total HSA assets reached $37.9 billion, a 14% increase, with investment assets growing 28% to $20.6 billion.